Stock data
LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. (LENZ) reported revenue of US$19.09M and net income of -US$82.13M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$19.09M | — | -US$91.14M | -US$82.13M | — |
| 2024 | US$0.00M | — | -US$58.61M | -US$49.77M | — |
| 2023 | — | — | -US$72.43M | -US$69.97M | — |
| 2022 | — | — | -US$105.64M | -US$101.05M | — |
| 2021 | — | — | -US$60.44M | -US$70.76M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$5.49M | -US$31.92M | — |
| 2026-03-31 | US$1.90M | -US$41.49M | — |
| 2025-12-31 | — | -US$35.90M | — |
| 2025-09-30 | — | -US$16.70M | — |
| 2025-06-30 | US$5.00M | -US$14.91M | — |
| 2025-03-31 | US$0.00M | -US$14.62M | — |
| 2024-12-31 | — | -US$12.65M | — |
| 2024-09-30 | — | -US$10.21M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.